Ayala Pharmaceuticals vs Dio Tree
Ayala Pharmaceuticals vs Dio Tree, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Ayala Pharmaceuticals is on 41/100 and Dio Tree on 44/100.
Where each one leads
Ayala Pharmaceuticals
- funding raised: $72.0M against $15.0M
Dio Tree
- our overall score: 44/100 against 41/100
- agent readiness: 50/100 against 32/100
At a glance
| Measure | Ayala Pharmaceuticals | Dio Tree |
|---|---|---|
| What it is | Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers. | Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3. |
| Category | Life Sciences, Oncology, Therapeutics, Biotech | Life Sciences, Oncology, Biotech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Drug discovery |
| Founded | 2017 | 2022 |
| Headquarters | Jerusalem, Israel | Cambridge, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Ayala Pharmaceuticals | Dio Tree |
|---|---|---|
| Total funding | $72.0M | $15.0M |
| Latest round | Series C | Seed |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Ayala Pharmaceuticals | Dio Tree |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 41/100 | 44/100 |
| Traction | 39/100 | 36/100 |
| Team | 50/100 | 70/100 |
| Search visibility | 3/100 | 4/100 |
| Quality | 45/100 | 50/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 29/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Ayala Pharmaceuticals | Dio Tree |
|---|---|---|
| CDN | Cloudflare | Not detected |
Ayala Pharmaceuticals vs Dio Tree: common questions
Which is better, Ayala Pharmaceuticals or Dio Tree?
On our 0-100 score Dio Tree rates higher (44/100 against 41/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Ayala Pharmaceuticals and Dio Tree compare on the numbers?
Ayala Pharmaceuticals leads on funding raised ($72.0M against $15.0M). Dio Tree leads on our overall score (44/100 against 41/100), agent readiness (50/100 against 32/100).
Read the full Ayala Pharmaceuticals review and pricing or the Dio Tree review and pricing. You can also browse other Ayala Pharmaceuticals alternatives we track.